JP Morgan Chase’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
JP Morgan Chase's HALO Position: Q1 2026 in Review
JP Morgan Chase increased its Halozyme (HALO) stake by 46% in Q1 2026, buying an estimated $14M and bringing the position to 633,730 shares worth $39.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1538.
JP Morgan Chase first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $239M in Q2 2021. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- JP Morgan Chase held 633,730 shares of Halozyme worth $39.4M as of Q1 2026.
- JP Morgan Chase bought 199,193 Halozyme shares in Q1 2026, an estimated $14M.
- Halozyme made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1538 holding.
- JP Morgan Chase first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Halozyme position peaked at $239M in Q2 2021.
- 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.